Story perspectives

Brain-controlled hearing aid boosts target speaker accuracy 90%

5/14/2026

Summary

Story summary

Researchers unveiled a brain-controlled hearing aid that amplifies the focused speaker using auditory-cortex signals.
In tests on four epilepsy patients with typical hearing, the device identified the target conversation up to 90% of the time.
Dr Frederika Holmes says voice analysis cannot give absolute certainty because voices change with circumstances.
Prof Sophie Scott notes vocal traits reveal height, gender, age, health, emotions and hormonal shifts such as pitch during ovulation.

History

Historical Context

Graeme Clark’s multi-channel Nucleus implant received FDA approval in 1985, and Cochlear Ltd. later commercialized it, reaching over 250,000 recipients by 2015. Building on that legacy, Dr. Frederika Holmes and Prof. Sophie Scott recently demonstrated a brain-controlled hearing aid that decodes auditory-cortex signals, showing how early cochlear-implant breakthroughs have enabled modern neural prosthetics.

1 of 2

Story summary

Researchers unveiled a brain-controlled hearing aid that amplifies the focused speaker using auditory-cortex signals.
In tests on four epilepsy patients with typical hearing, the device identified the target conversation up to 90% of the time.
Dr Frederika Holmes says voice analysis cannot give absolute certainty because voices change with circumstances.
Prof Sophie Scott notes vocal traits reveal height, gender, age, health, emotions and hormonal shifts such as pitch during ovulation.

1 / 2